Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person

A hallmark of the human cell cycle in normal somatic cell...

Class:IdSummation:69621
_displayName

A hallmark of the human cell cycle in normal somatic cell...

_timestamp2025-04-04 17:18:56
created[InstanceEdit:69619] Hoffmann, I, Khanna, KK, Walworth, N, Yen, Tim, O'Donnell, M, 2005-01-01
literatureReference[LiteratureReference:9944008] Cell Cycle Control: A System of Interlinking Oscillators
[LiteratureReference:9944003] Cell cycle checkpoints: the role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases
[LiteratureReference:9944001] Time-keeping and decision-making in the cell cycle
[LiteratureReference:9944005] The Hammer and the Dance of Cell Cycle Control
[LiteratureReference:9943997] Targeting DNA damage response pathways in cancer
[LiteratureReference:9944000] Cell cycle control, checkpoint mechanisms, and genotoxic stress
modified[InstanceEdit:73879] Joshi-Tope, G, 2007-09-03 10:09:00
[InstanceEdit:77572] Joshi-Tope, G, 2003-10-30 03:18:00
[InstanceEdit:114232] Joshi-Tope, G, 2004-06-28 01:26:42
[InstanceEdit:157523] Joshi-Tope, G, 2005-01-01 01:09:04
[InstanceEdit:157524] Joshi-Tope, G, 2005-01-01 01:09:29
[InstanceEdit:158014] Joshi-Tope, G, 2005-01-12 20:26:26
[InstanceEdit:9943974] Orlic-Milacic, Marija, 2025-04-01
[InstanceEdit:9944014] Orlic-Milacic, Marija, 2025-04-01
[InstanceEdit:9944015] Orlic-Milacic, Marija, 2025-04-01
[InstanceEdit:9944337] Orlic-Milacic, Marija, 2025-04-04
text

A hallmark of the human cell cycle in normal somatic cells is its precision. This remarkable fidelity is achieved by a number of signal transduction pathways, known as checkpoints, which monitor cell cycle progression ensuring an interdependency of S phase and mitosis, the integrity of the genome and the fidelity of chromosome segregation (reviewed in Shackelford et al. 1999, Panagopoulos and Altmeyer 2021, Tyson and Novak 2022).

Checkpoints are layers of control that act to delay CDK activation when defects in the division program occur. As the CDKs functioning at different points in the cell cycle are regulated by different means, the various checkpoints differ in the biochemical mechanisms by which they elicit their effect. However, all checkpoints share a common hierarchy of a sensor, signal transducers, and effectors that interact with the CDKs (reviewed in Poon 2016).

Depending on the stage of the cell cycle that they regulate, the cell cycle checkpoints are divided into G1/S checkpoints, S phase checkpoints, G2/M checkpoints, and M/G1 checkpoints (reviewed in Poon 2016). Reactome currently has partial coverage of G1/S checkpoints (pathway G1/S DNA Damage Checkpoints), G2/M checkpoints (pathway G2/M Checkpoints), and M/G1 checkpoints (pathway Mitotic Spindle Checkpoint).

The stability of the genome in somatic cells contrasts to the almost universal genomic instability of tumor cells. There are a number of documented genetic lesions in checkpoint genes, or in cell cycle genes themselves, which result either directly in cancer or in a predisposition to certain cancer types. Indeed, restraint over cell cycle progression and failure to monitor genome integrity are likely prerequisites for the molecular evolution required for the development of a tumor. Perhaps most notable amongst these is the TP53 (p53) tumor suppressor gene, which is mutated in >50% of human tumors. Thus, the importance of the checkpoint pathways to human biology is clear (reviewed in Golubnitschaja 2007, Groelly et al. 2023).

(summation)[Pathway:69620] Cell Cycle Checkpoints [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by

A hallmark of the human cell cycle in normal somatic cell... (69621)